MedTrace Logo

Study of Dual Trigger Ovulation in Oocyte Donors

NCT01443546 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2019-06-26

Study results available
· View outcomes & findings →

Summary

The project is a randomized, controlled, prospective study of oocyte donors comparing the safety and efficacy of triggering ovulation using a combination of two drugs-GnRH agonist and very low dose hCG-versus triggering ovulation with a standard hCG dose alone or a standard GnRH trigger alone.

Conditions

Interventions

DRUG

HCG

hCG Trigger

DRUG

Lupron Trigger

leuprolide acetate 2 mg SQ

DRUG

Dual Trigger

a combination of the two drugs in low dosage (leuprolide acetate 2 mg and hCG 1500 IU).

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01443546 on ClinicalTrials.gov